Literature DB >> 18362478

Mathematical models for prognostic prediction in patients with renal cell carcinoma.

Antonio Galfano1, Giacomo Novara, Massimo Iafrate, Stefano Cavalleri, Guido Martignoni, Marina Gardiman, Carolina D'Elia, Jean Jacques Patard, Walter Artibani, Vincenzo Ficarra.   

Abstract

OBJECTIVES: The objectives of this study are to catalogue all models developed to predict survival of RCC patients and to identify the ones to be used in different situations.
METHODS: A systematic review was performed searching with a free text and MeSH strategy 3 electronic databases. For each model, the following parameters were identified: number, features of the patients; evaluation endpoints; clinical and/or pathological variables included; concordance indexes (cI).
RESULTS: The research retrieved 156 records. Eleven articles proposed new models, 5 articles external validations. We retrieved 2 mathematical models including clinical variables only (Yaycioglu, cI 0.651; Cindolo, cI 0.672); 2 algorithms including also pathological variables (SSIGN, cI 0.819; UISS, cI 0.79-0.84), 5 nomograms (Kattan, cI 0.76-0.86; Sorbellini, cI 0.82; Kim 2004, cI 0.79, Kim 2005, cI 0.68; Karakiewicz, cI 0.86); 2 algorithms for patients with metastatic disease (Motzer, Leibovich).
CONCLUSIONS: The SSIGN was the most accurate algorithm for conventional RCC, while the UISS allowed the evaluation of patients regardless of tumor histotype. The Sorbellini nomogram is applicable only for patients with conventional RCC, while the Kattan and Karakiewicz nomograms also provide information for other histotypes. Metastatic patients can be evaluated with Leibovich and Motzer algorithms. Two models combine molecular markers and clinical features (Kim 2004-2005).

Entities:  

Mesh:

Year:  2008        PMID: 18362478     DOI: 10.1159/000112599

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  8 in total

1.  Decision curve analysis and external validation of the postoperative Karakiewicz nomogram for renal cell carcinoma based on a large single-center study cohort.

Authors:  Stefan Zastrow; Sabine Brookman-May; Thi Anh Phuong Cong; Stanislaw Jurk; Immanuel von Bar; Vladimir Novotny; Manfred Wirth
Journal:  World J Urol       Date:  2014-05-22       Impact factor: 4.226

Review 2.  The current status of tailor-made medicine with molecular biomarkers for patients with clear cell renal cell carcinoma.

Authors:  Sunao Shoji; Mayura Nakano; Haruhiro Sato; Xian Yang Tang; Yoshiyuki Robert Osamura; Toshiro Terachi; Toyoaki Uchida; Koichi Takeya
Journal:  Clin Exp Metastasis       Date:  2014-01       Impact factor: 5.150

Review 3.  Kidney transplantation in patients with previous renal cancer: a critical appraisal of current evidence and guidelines.

Authors:  Giovanni M Frascà; Fabiana Brigante; Alessandro Volpe; Laura Cosmai; Maurizio Gallieni; Camillo Porta
Journal:  J Nephrol       Date:  2018-10-16       Impact factor: 3.902

4.  Improving the accuracy of pre-operative survival prediction in renal cell carcinoma with C-reactive protein.

Authors:  S P K Jagdev; W Gregory; N S Vasudev; P Harnden; S Sim; D Thompson; J Cartledge; P J Selby; R E Banks
Journal:  Br J Cancer       Date:  2010-11-09       Impact factor: 7.640

5.  Association of serum amyloid A protein and peptide fragments with prognosis in renal cancer.

Authors:  S L Wood; M Rogers; D A Cairns; A Paul; D Thompson; N S Vasudev; P J Selby; R E Banks
Journal:  Br J Cancer       Date:  2010-06-08       Impact factor: 7.640

Review 6.  Overview of Current and Future Adjuvant Therapy for High-Risk Localized Renal Cell Carcinoma.

Authors:  Lakshminarayanan Nandagopal; Gurudatta Naik; Guru Sonpavde
Journal:  Curr Treat Options Oncol       Date:  2018-01-18

7.  C-reactive protein in patients with advanced metastatic renal cell carcinoma: usefulness in identifying patients most likely to benefit from initial nephrectomy.

Authors:  Hiroki Ito; Koichi Shioi; Takayuki Murakami; Akitoshi Takizawa; Futoshi Sano; Takashi Kawahara; Nobuhiko Mizuno; Kazuhide Makiyama; Noboru Nakaigawa; Takeshi Kishida; Takeshi Miura; Yoshinobu Kubota; Masahiro Yao
Journal:  BMC Cancer       Date:  2012-08-02       Impact factor: 4.430

8.  Alteration of gene expression signatures of cortical differentiation and wound response in lethal clear cell renal cell carcinomas.

Authors:  Hongjuan Zhao; Robert Tibshirani; John P T Higgins; Börje Ljungberg; James D Brooks
Journal:  PLoS One       Date:  2009-06-25       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.